People: Collegium Pharmaceutical Inc (COLL.OQ)
19 Jul 2019
Dr. Alison B. Fleming Ph.D., is the Executive Vice President and Chief Technology Officer of Collegium Pharmaceutical Inc. Prior to being our Chief Technology Officer, Dr. Fleming led our development team as our Vice President, Product Development since October 2002. Prior to joining us, Dr. Fleming's academic research focused on implantable drug delivery systems for cancer therapy. Dr. Fleming is an inventor on several U.S. patents and pending patent applications, and has authored numerous scientific publications and poster presentations in the field of novel drug delivery systems and abuse-deterrent opioid formulations. Dr. Fleming graduated from the University of Massachusetts, Amherst in 1997 with a B.S. in Chemical Engineering and received a Ph.D. in Chemical and Biomolecular Engineering from Cornell University in 2002.
|Total Annual Compensation, USD||346,154|
|Restricted Stock Award, USD||608,750|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||954,262|
|Fiscal Year Total, USD||1,909,170|